DC
NXTM

Deere & Company’s NxStage Medical Inc. NXTM Stock Holding History

Deere & Company’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,605
Closed -$515K – 908
2016
Q3 		$515K Hold
20,605
– – 0.03% 599
2016
Q2 		$447K Sell
20,605
-7,531
-27% -$134K 0.02% 671
2016
Q1 		$422K Hold
28,136
– – 0.02% 700
2015
Q4 		$616K Buy
+28,136
New +$524K 0.04% 452
2013
Q3 		– Sell
-16,284
Closed -$233K – 1107
2013
Q2 		$233K Buy
+16,284
New +$205K 0.01% 791

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's NXTM Position: Q4 2016 in Review

Deere & Company sold out of NxStage Medical Inc. (NXTM) in Q4 2016, closing a stake of 20,605 shares — an estimated $515K sold.

Deere & Company first reported a position in NXTM in Q2 2013 and held it in 5 quarters. The position peaked at $616K in Q4 2015. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • Deere & Company reported no remaining NxStage Medical Inc. position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 20,605 NxStage Medical Inc. shares in Q4 2016, an estimated $515K.
  • Deere & Company first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 5 quarters.
  • Deere & Company's NxStage Medical Inc. position peaked at $616K in Q4 2015.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.